Why the study?
Does aldosterone infusion alter the density and affinity of vascular angiotensin II receptors in rats?
Does aldosterone infusion alter the density and affinity of vascular angiotensin II receptors in rats?
Aldosterone up-regulates vascular angiotensin II receptors independently of plasma renin activity, potentially antagonizing the down-regulating action of angiotensin II.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for aldosterone-angiotensin II receptor crosstalk in rats; leaves open relevance to human hypertension or dual RAAS blockade.
The effect of aldosterone on the density and affinity of binding sites for 125I-labelled angiotensin II was investigated in a particulate fraction prepared from the rat mesenteric arteriolar arcades. The infusion of aldosterone 6.6 micrograms/h intraperitoneally via Alzet osmotic minipumps for 6 d produced an increase in the density of binding sites for 125I-labelled angiotensin II without change in affinity. After sodium depletion, mesenteric artery angiotensin II receptors were down-regulated as expected. An increase in the number of binding sites could be found when aldosterone was infused into sodium-depleted rats with no change in the elevated plasma renin activity. The intraperitoneal infusion of angiotensin II (200 ng X kg-1 X min-1 for 6 d) simultaneously with aldosterone resulted in down-regulation of vascular angiotensin II receptors, whereas after intravenous angiotensin II infusion (at 60 ng X kg-1 X min-1) the density of angiotensin II binding sites rose with aldosterone infusion. Plasma renin activity (PRA) was reduced and plasma angiotensin II increased in a dose-dependent fashion after angiotensin II infusion. An aldosterone concentration of 3 ng/mL for 18 h produced an increase in the number of angiotensin II binding sites in rat mesenteric artery smooth muscle cells in culture. We conclude that increased plasma aldosterone may result in up-regulation of vascular angiotensin II receptors independently of changes in plasma renin activity, and may in certain physiological states effectively antagonize the down-regulating action of angiotensin II.
No takes yet. Share an insight, caveat, or question.
Schiffrin et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: